NCL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.856800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.339200E-01
Normal-vs-Stage2
7.553600E-01
Normal-vs-Stage3
8.240800E-01
Normal-vs-Stage4
1.619830E-01
Stage1-vs-Stage2
4.959400E-01
Stage1-vs-Stage3
9.430200E-01
Stage1-vs-Stage4
7.889700E-02
Stage2-vs-Stage3
5.280400E-01
Stage2-vs-Stage4
1.665840E-01
Stage3-vs-Stage4
1.497160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.787400E-01
Normal-vs-AfricanAmerican
7.461800E-01
Normal-vs-Asian
9.353000E-01
Caucasian-vs-AfricanAmerican
9.525200E-01
Caucasian-vs-Asian
7.319400E-01
AfricanAmerican-vs-Asian
8.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.165600E-01
Normal-vs-Female
7.513200E-01
Male-vs-Female
5.475800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.481000E-01
Normal-vs-Age(41-60Yrs)
5.851800E-01
Normal-vs-Age(61-80Yrs)
9.206800E-01
Normal-vs-Age(81-100Yrs)
5.091000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.845200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.879200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.511200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.792400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.644800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.085200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.836600E-01
Normal-vs-Daily Drinker
9.445000E-01
Normal-vs-Weekly Drinker
7.952000E-01
Normal-vs-Occasional Drinker
3.663800E-01
Normal-vs-Social Drinker
8.877600E-01
Non Drinker-vs-Daily Drinker
6.440800E-01
Non Drinker-vs-Weekly Drinker
8.497600E-01
Non Drinker-vs-Occasional Drinker
3.867800E-01
Non Drinker-vs-Social Drinker
8.635400E-01
Daily Drinker-vs-Weekly Drinker
5.142000E-01
Daily Drinker-vs-Occasional Drinker
1.131790E-01
Daily Drinker-vs-Social Drinker
7.200000E-01
Weekly Drinker-vs-Occasional Drinker
6.397800E-01
Weekly Drinker-vs-Social Drinker
7.276600E-01
Occasional Drinker-vs-Social Drinker
2.076200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.616000E-01
Normal-vs-Grade 2
1.175430E-01
Normal-vs-Grade 3
1.398040E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.003200E-03
Grade 1-vs-Grade 3
2.497600E-03
Grade 1-vs-Grade 4
4.616000E-01
Grade 2-vs-Grade 3
1.677200E-01
Grade 2-vs-Grade 4
1.175430E-01
Grade 3-vs-Grade 4
1.398040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.777400E-01
Normal-vs-NonDiabetic
8.422200E-01
Diabetic-vs-NonDiabetic
8.468400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.804800E-01
Normal-vs-NoPancreatitis
7.996600E-01
Pancreatitis-vs-NoPancreatitis
1.714030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.881400E-01
Normal-vs-N1
7.070800E-01
N0-vs-N1
2.549200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.683000E-01
Normal-vs-TP53-NonMutant
9.085400E-01
TP53-Mutant-vs-TP53-NonMutant
1.93000999999526E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
